In addition, the presence of N17 H-Ras greatly attenuated BCR/ABL-induced chronic myelogenous leukemia (CML)-like myeloproliferative disease. This evidence concerns the gene HRAS and chronic myelogenous leukemia, BCR-ABL1 positive.